期刊文献+

狼疮性肾炎患者血浆与肾组织抗中性粒细胞胞浆抗体的表达

Expression of ANCA in blood and kidney tissue of patients with lupus nephritis
暂未订购
导出
摘要 目的探讨抗中性粒细胞胞浆抗体(ANCA)在狼疮性肾炎(LN)患者血浆及肾组织中的表达及其意义。方法回顾性分析40例LN患者的临床资料及ANCA检测结果,按。肾脏病变活动性评分、系统性红斑狼疮疾病活动性指数(SLEDAI)评分、尿蛋白含量进行分类统计。结果血浆ANCA阳性率为37.5%,肾组织ANCA阳性率为42.5%,两者呈正相关性(r=0.765,P=0.013),但无统计学差异。肾脏活动性病变组的血浆ANCA和肾组织ANCA阳性率均高于肾脏慢性化病变组(P〈0.05,P〈0.01),高尿蛋白组肾组织ANCA阳性率明显高于低尿蛋白组(P〈0.01)。结论ANCA可作为判断狼疮性肾炎(LN)肾脏病变及临床活动性的重要参考指标。 Objective To study the expression of antineutrophil cytoplasmic antibody (ANCA) in blood and kidney tissues of patients with lupus nephritis (LN). Methods The clinical data and results of ANCA test in 40 patients with LN were analyzed retrospectively according to activity of LN, scores of SLEDAI and urine protein. Results Positive rate of ANCA expression in blood and kidney tissue was 37.5% and 42.5%, respectively. Blood ANCA was positively correlated with kidney ANCA (r=0.765,P =0.013), but there was no significant difference between two groups. Positive rate of ANCA expression in blood and kidney tissue in active lesion group was significantly higher than that in chronic lesion group(P〈0.05, P〈0.01). Furthermore, kidney ANCA positive rate in high urine protein group was significantly higher than that in low urine protein group(P〈0.01). Conclusion ANCA is a significant reference on evaluating the activity of LN.
出处 《临床肾脏病杂志》 2009年第10期266-267,共2页 Journal Of Clinical Nephrology
关键词 肾炎 狼疮性 抗体 抗中性白细胞胞质 诊断 Nephritis, lupus Antibodies, Antineutrophil cytoplasmic Diagnosis
  • 相关文献

参考文献7

二级参考文献60

  • 1孙雪峰,苏金环,叶任高.中西医结合治疗狼疮性肾炎的荟萃分析(英文)[J].中国现代医学杂志,2004,14(17):23-28. 被引量:5
  • 2叶任高,任国辉,李惠群,李幼姬,王明银,侯宝渊.中西医结合治疗狼疮性肾炎74例疗效观察[J].中国中西医结合杂志,1994,14(6):343-345. 被引量:46
  • 3蒋克春,风湿病学杂志,1996年,1期,130页
  • 4叶任高.内科学·第5版[M].北京:人民卫生出版社,2000.798-820.
  • 5Schnable A, Cserno KE, Isenberg DA, et aL Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus:Prevalence, specificities,and clinical significance [J]. Arthritis Rheum, 1995, 38: 633-7.
  • 6Pradhan VD, Badakere SS, Bichile LS, et al. Antineutrophil cytoplasmic antibodies (ANCA) in systemic lupus erythematosus:prevalence, clinical associations and correlations with other autoantibodies[J]. J Assoc Physicians India, 2004, 52: 533-7.
  • 7Gross WL, Csemok E. Immunodiagnostic and pathophysiological aspects of antineutrophil cytoplasmic autoantibodies in vasculities[J]. Curr Opin Rheumatol, 1995, 7(1): 11-9.
  • 8Fauzi AR, Kong NC, Chua MK, et al. Antibodies in systemic lupus antineutrophil cytoplasmic erythematosus: prevalence, disease activity correlations and organ system associations [J]. Med J Malaysia, 2004, 59(3): 372-7.
  • 9Franssen CFM, Stegen CA, Kallenberg CGM, et al. Antiproteinase 3 and antimyeloperoxidase associated vasculitis [J]. Kidney Intern,2000, 57: 2195-206.
  • 10Singh RR, Malaviya AN, Kailash S, et al. Clinical significance of antibody in systemic lupus crythematosus & related disorders [J].Indian J Med Res, 1991, 94: 206.

共引文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部